Synthetische Derivate des humanen Cathelicidins hCAP18/LL37 sind potentielle, antitumorale Medikamente
dc.affiliation.institute | Klinik für Hals-, Nasen- und Ohrenheilkunde | de |
dc.contributor.author | Röbke, Christina | |
dc.contributor.referee | Meyer, Jens E. | |
dc.contributor.referee | Gutsmann, Thomas | |
dc.date.accepted | 2011 | |
dc.date.accessioned | 2023-08-01T07:13:19Z | |
dc.date.available | 2023-08-01T07:13:19Z | |
dc.date.issued | 2011 | |
dc.identifier.dnbppn | 1014152011 | |
dc.identifier.gbvppn | 667946071 | |
dc.identifier.uri | https://epub.uni-luebeck.de/handle/zhb_hl/1336 | |
dc.identifier.urn | urn:nbn:de:gbv:841-20110527270 | |
dc.language | ger | |
dc.language.iso | de | |
dc.language.rfc3066 | de-DE | |
dc.publisher.department | Sektion Naturwissenschaften | de |
dc.publisher.place | Lübeck | de |
dc.subject.ddc | 610 | |
dc.title | Synthetische Derivate des humanen Cathelicidins hCAP18/LL37 sind potentielle, antitumorale Medikamente | de |
dc.type | thesis.doctoral |
Dateien
Originalbündel
1 - 1 von 1